APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bradykinin B1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bradykinin B1 Receptor Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchBradykinin B1 Receptor Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Bradykinin B1 Receptor Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Bradykinin B1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bradykinin B1 Receptor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Bradykinin B1 Receptor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bradykinin B1 Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bradykinin B1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bradykinin B1 Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bradykinin B1 Receptor market include Grunenthal GmbH, Dompe Farmaceutici S.p.A., Boehringer Ingelheim GmbH and Axxam SpA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bradykinin B1 Receptor market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bradykinin B1 Receptor and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bradykinin B1 Receptor revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bradykinin B1 Receptor market.

Bradykinin B1 Receptor Segment by Company

Grunenthal GmbH

Dompe Farmaceutici S.p.A.

Boehringer Ingelheim GmbH

Axxam SpA

Bradykinin B1 Receptor Segment by Type

BI-113823

Others

Bradykinin B1 Receptor Segment by Application

Clinic

Hospital

Household

Bradykinin B1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bradykinin B1 Receptor status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bradykinin B1 Receptor key companies, revenue, market share, and recent developments.

3. To split the Bradykinin B1 Receptor breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bradykinin B1 Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bradykinin B1 Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Bradykinin B1 Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bradykinin B1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bradykinin B1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bradykinin B1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bradykinin B1 Receptor industry.

Chapter 3: Detailed analysis of Bradykinin B1 Receptor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bradykinin B1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bradykinin B1 Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bradykinin B1 Receptor Industry Trends Table 2. Bradykinin B1 Receptor Industry Drivers Table 3. Bradykinin B1 Receptor Industry Opportunities and Challenges Table 4. Bradykinin B1 Receptor Industry Restraints Table 5. Global Bradykinin B1 Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bradykinin B1 Receptor Revenue Share by Company (2021-2026) Table 7. Global Bradykinin B1 Receptor Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bradykinin B1 Receptor Key Company Manufacturing Base & Headquarters Table 9. Global Bradykinin B1 Receptor Company, Product Type & Application Table 10. Global Bradykinin B1 Receptor Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bradykinin B1 Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of BI-113823 Table 15. Significant Companies of Others Table 16. Global Bradykinin B1 Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Bradykinin B1 Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Bradykinin B1 Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Bradykinin B1 Receptor Sales Value Share by Type (2021-2026) Table 20. Global Bradykinin B1 Receptor Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinic Table 22. Significant Companies of Hospital Table 23. Significant Companies of Household Table 24. Global Bradykinin B1 Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bradykinin B1 Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Bradykinin B1 Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Bradykinin B1 Receptor Sales Value Share by Application (2021-2026) Table 28. Global Bradykinin B1 Receptor Sales Value Share by Application (2027-2032) Table 29. Global Bradykinin B1 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Bradykinin B1 Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Bradykinin B1 Receptor Sales Value Share by Region (2021-2026) Table 32. Global Bradykinin B1 Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Bradykinin B1 Receptor Sales Value Share by Region (2027-2032) Table 34. Global Bradykinin B1 Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Bradykinin B1 Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Bradykinin B1 Receptor Sales Value Market Share by Country (2021-2026) Table 37. Global Bradykinin B1 Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Bradykinin B1 Receptor Sales Value Market Share by Country (2027-2032) Table 39. Grunenthal GmbH Company Information Table 40. Grunenthal GmbH Business Overview Table 41. Grunenthal GmbH Bradykinin B1 Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Grunenthal GmbH Bradykinin B1 Receptor Product Portfolio Table 43. Grunenthal GmbH Recent Development Table 44. Dompe Farmaceutici S.p.A. Company Information Table 45. Dompe Farmaceutici S.p.A. Business Overview Table 46. Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Product Portfolio Table 48. Dompe Farmaceutici S.p.A. Recent Development Table 49. Boehringer Ingelheim GmbH Company Information Table 50. Boehringer Ingelheim GmbH Business Overview Table 51. Boehringer Ingelheim GmbH Bradykinin B1 Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Boehringer Ingelheim GmbH Bradykinin B1 Receptor Product Portfolio Table 53. Boehringer Ingelheim GmbH Recent Development Table 54. Axxam SpA Company Information Table 55. Axxam SpA Business Overview Table 56. Axxam SpA Bradykinin B1 Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Axxam SpA Bradykinin B1 Receptor Product Portfolio Table 58. Axxam SpA Recent Development Table 59. Research Programs/Design for This Report Table 60. Authors List of This Report Table 61. Secondary Sources Table 62. Primary Sources List of Figures Figure 1. Bradykinin B1 Receptor Product Image Figure 2. Global Bradykinin B1 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bradykinin B1 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Bradykinin B1 Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. BI-113823 Image Figure 8. Others Image Figure 9. Global Bradykinin B1 Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Bradykinin B1 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Bradykinin B1 Receptor Sales Value Share by Type (2021-2032) Figure 12. Clinic Image Figure 13. Hospital Image Figure 14. Household Image Figure 15. Global Bradykinin B1 Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bradykinin B1 Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bradykinin B1 Receptor Sales Value Share by Application (2021-2032) Figure 18. Global Bradykinin B1 Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Bradykinin B1 Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Bradykinin B1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 21. North America Bradykinin B1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Bradykinin B1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Bradykinin B1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Bradykinin B1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Bradykinin B1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Bradykinin B1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 27. South America Bradykinin B1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Bradykinin B1 Receptor Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Bradykinin B1 Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • BI-113823
  • Others
Applications
  • Clinic
  • Hospital
  • Household
Companies covered
  • Grunenthal GmbH
  • Dompe Farmaceutici S.p.A.
  • Boehringer Ingelheim GmbH
  • Axxam SpA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bradykinin B1 Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bradykinin B1 Receptor Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bradykinin B1 Receptor Market Dynamics
  1. 2.1 Bradykinin B1 Receptor Industry Trends
  2. 2.2 Bradykinin B1 Receptor Industry Drivers
  3. 2.3 Bradykinin B1 Receptor Industry Opportunities and Challenges
  4. 2.4 Bradykinin B1 Receptor Industry Restraints
3 Bradykinin B1 Receptor Market by Company
  1. 3.1 Global Bradykinin B1 Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Bradykinin B1 Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Bradykinin B1 Receptor Company Ranking (2024-2026)
  4. 3.4 Global Bradykinin B1 Receptor Company Manufacturing Base and Headquarters
  5. 3.5 Global Bradykinin B1 Receptor Company Product Type and Application
  6. 3.6 Global Bradykinin B1 Receptor Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bradykinin B1 Receptor Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bradykinin B1 Receptor Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bradykinin B1 Receptor Market by Type
  1. 4.1 Bradykinin B1 Receptor Type Introduction
  2. 4.1.1 BI-113823
  3. 4.1.2 Others
  4. 4.2 Global Bradykinin B1 Receptor Sales Value by Type
  5. 4.2.1 Global Bradykinin B1 Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bradykinin B1 Receptor Sales Value by Type (2021-2032)
  7. 4.2.3 Global Bradykinin B1 Receptor Sales Value Share by Type (2021-2032)
5 Bradykinin B1 Receptor Market by Application
  1. 5.1 Bradykinin B1 Receptor Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Household
  5. 5.2 Global Bradykinin B1 Receptor Sales Value by Application
  6. 5.2.1 Global Bradykinin B1 Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bradykinin B1 Receptor Sales Value by Application (2021-2032)
  8. 5.2.3 Global Bradykinin B1 Receptor Sales Value Share by Application (2021-2032)
6 Bradykinin B1 Receptor Regional Value Analysis
  1. 6.1 Global Bradykinin B1 Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bradykinin B1 Receptor Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bradykinin B1 Receptor Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bradykinin B1 Receptor Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bradykinin B1 Receptor Sales Value (2021-2032)
  7. 6.3.2 North America Bradykinin B1 Receptor Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bradykinin B1 Receptor Sales Value (2021-2032)
  10. 6.4.2 Europe Bradykinin B1 Receptor Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bradykinin B1 Receptor Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bradykinin B1 Receptor Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bradykinin B1 Receptor Sales Value (2021-2032)
  16. 6.6.2 South America Bradykinin B1 Receptor Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bradykinin B1 Receptor Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bradykinin B1 Receptor Sales Value Share by Country, 2025 VS 2032
7 Bradykinin B1 Receptor Country-level Value Analysis
  1. 7.1 Global Bradykinin B1 Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bradykinin B1 Receptor Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bradykinin B1 Receptor Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bradykinin B1 Receptor Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bradykinin B1 Receptor Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bradykinin B1 Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bradykinin B1 Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Grunenthal GmbH
  2. 8.1.1 Grunenthal GmbH Company Information
  3. 8.1.2 Grunenthal GmbH Business Overview
  4. 8.1.3 Grunenthal GmbH Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Grunenthal GmbH Bradykinin B1 Receptor Product Portfolio
  6. 8.1.5 Grunenthal GmbH Recent Developments
  7. 8.2 Dompe Farmaceutici S.p.A.
  8. 8.2.1 Dompe Farmaceutici S.p.A. Company Information
  9. 8.2.2 Dompe Farmaceutici S.p.A. Business Overview
  10. 8.2.3 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dompe Farmaceutici S.p.A. Bradykinin B1 Receptor Product Portfolio
  12. 8.2.5 Dompe Farmaceutici S.p.A. Recent Developments
  13. 8.3 Boehringer Ingelheim GmbH
  14. 8.3.1 Boehringer Ingelheim GmbH Company Information
  15. 8.3.2 Boehringer Ingelheim GmbH Business Overview
  16. 8.3.3 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim GmbH Bradykinin B1 Receptor Product Portfolio
  18. 8.3.5 Boehringer Ingelheim GmbH Recent Developments
  19. 8.4 Axxam SpA
  20. 8.4.1 Axxam SpA Company Information
  21. 8.4.2 Axxam SpA Business Overview
  22. 8.4.3 Axxam SpA Bradykinin B1 Receptor Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Axxam SpA Bradykinin B1 Receptor Product Portfolio
  24. 8.4.5 Axxam SpA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst